VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
HYPR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
HYPRHyperfine, Inc.
$0.80$68M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HYPR logo

Hyperfine, Inc.

HYPR
NASDAQ · Medical Devices
$0.80
At close - Sep 23, 4:00 PM EDT - USD
Market Cap$68M
P/E-1.9x
52W High$2.22
Volume586.33K
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q1

Persistent Operating Losses Threaten Capital Sustainability

Hyperfine faces a challenging path to profitability as it struggles to scale its proprietary low-field MRI technology amidst volatile revenue growth and significant operational overhead. While the company maintains a current ratio of 5.52, the consistent quart...

GrowthMixed
ProfitabilityNegative
ValuationReview
TechnicalsWeak
Explore valuation models
MARKET ACTION

HYPR price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

3/12 Beats

EPS beat 3 of last 12 quarters

02

Valuation risk

-106% Peers

P/E is 106% below peer median

03

Market leadership

RS 15 · Lag

Laggard (Underperforming 85% of market)

04

Weak Trend

Below 200DMA

Price < 200DMA

Next CatalystConfirmed earnings · Nov 12

Market performance

Price History →

Trailing total returns as of 9/24/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
HYPR-17.16%
S&P 500 (^GSPC)+12.39%
1-Year Return
HYPR-45.03%
S&P 500 (^GSPC)+15.77%
3-Year Return
HYPR-59.87%
S&P 500 (^GSPC)+77.84%
5-Year Return
HYPR-91.91%
S&P 500 (^GSPC)+72.91%

Growth & profitability

Annual revenue & EPS trend
Revenue
$14M+5.2% YoY
Net income
-$36M+12.6% YoY
Free cash flow
-$29M+25.6% YoY
Operating margin
-273.4%+61.9 pts YoY
ROIC (TTM)-310.8%
Avg ROIC 5Y-
ROE (TTM)-79%
Piotroski Score3 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate3/12 (25%)
Revenue Beat Rate6/12 (50%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026Latest
May 12, 2026
-$0.09+0.0%
vs -$0.09
$4M+10.3%
vs $4M
Q2 2026
Mar 18, 2026
-$0.08+0.0%
vs -$0.08
$5M+2.7%
vs $5M
Q4 2025
Nov 13, 2025
-$0.11-10.0%
vs -$0.10
$3M-35.2%
vs $5M
Q3 2025
Aug 13, 2025
-$0.12+0.0%
vs -$0.12
$3M-10.1%
vs $3M
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

5 Stories
Business Wire·Sep 16, 2026
MedtechWOMEN Names Hyperfine CEO Maria Sainz Winner of 2026 Ferolyn Powell Leadership Award

MENLO PARK, Calif.--(BUSINESS WIRE)--MedtechWOMEN today announced that Maria Sainz, President and CEO of Hyperfine, Inc., has been named the recipient of its 2026 Ferolyn Powell Leadership Award, and that Beverly Tang, co-founder and CEO of Starlight Cardiovascular, has received MedtechWOMEN's first-ever Rising Star Award. Both leaders were recognized at the annual MedtechVISION Annual Conference at the Rosewood Sand Hill in Menlo Park, Calif. Since 2016, the Ferolyn Powell Leadership Award has.

Business Wire·Sep 15, 2026
Hyperfine Announces Completion of Enrollment in the Contrast PMR Study to Support the Submission to Expand Indications for Use of the Swoop® System with Contrast Agents

GUILFORD, Conn.--(BUSINESS WIRE)--Completion of enrollment in study to support anticipated indication expansion for use of the Swoop® system with contrast agents.

Business Wire·Aug 31, 2026
Hyperfine, Inc. to Participate in Lake Street Capital Markets 10th Annual Best Ideas Growth Conference

GUILFORD, Conn.--(BUSINESS WIRE)--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced plans to participate in the upcoming Lake Street Capital Markets 10th Annual Best Ideas Growth Conference on Thursday, September 10th. Management will be hosting in-person meetings. To schedule a meeting with management, please reach out to your Lak.

GuruFocus·Aug 26, 2026
Hyperfine Builds Momentum in Year One of Neurology Office Launch with NEURO PMR Publication and More Than 3,000 Scans

[url="]Hyperfine, Inc.[/url] (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered

Filtered for Hyperfine, Inc.More Headlines
04

Compare before deciding

Benchmark HYPR against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for Hyperfine, Inc. (HYPR)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
HYPR logoHYPRHyperfine, Inc.Current
$0.80$67.59M-1.875.22%-262.29%-79.01%—
PRCT logoPRCTPROCEPT BioRobotics Corporation
$18.09$1.03B-10.5237.22%-32.54%-30.62%—
NVCR logoNVCRNovocure Ltd
$16.25$1.88B-13.328.28%-21.25%-44%—
INVA logoINVAInnoviva, Inc.
$20.24$1.49B6.1318.52%80.56%30.03%—
AEYE logoAEYEAudioEye, Inc.
$7.14$89.2M-28.5614.52%-10.92%-108.8%—
GEHC logoGEHCGE HealthCare Technologies Inc.
$66.09$29.85B14.534.84%7.86%14.91%—

Compare HYPR vs Peers

Hyperfine, Inc. (HYPR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs PRCT

Most directly comparable listed peer for HYPR.

Scale Benchmark

vs NVDA

Larger-name benchmark to compare HYPR against a more recognizable public peer.

Peer Set

Compare Top 5

vs PRCT, NVCR, INVA, AEYE

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

HYPR SEC Filings & Documents

Hyperfine, Inc. (HYPR) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Aug 6, 2026·SEC

Material company update

May 21, 2026·SEC

Material company update

May 12, 2026·SEC

10-K Annual Reports

3
FY 2026

Mar 18, 2026·SEC

FY 2025

Mar 17, 2025·SEC

FY 2024

Mar 22, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Aug 6, 2026·SEC

FY 2026

May 12, 2026·SEC

FY 2025

Nov 13, 2025·SEC

Get notified when HYPR posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

HYPR Frequently Asked Questions

Hyperfine, Inc. (HYPR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Hyperfine, Inc.'s revenue?

Hyperfine, Inc. (HYPR) reported $16.5M in revenue for fiscal year 2025.

How fast is Hyperfine, Inc. growing?

Hyperfine, Inc. (HYPR) grew revenue by 5.2% over the past year. This is steady growth.

Is HYPR profitable?

Hyperfine, Inc. (HYPR) reported a net loss of $34.9M for fiscal year 2025.

Dividend & Returns
What is HYPR's return on equity?

Hyperfine, Inc. (HYPR) has a return on equity (ROE) of -79.0%. Negative ROE indicates the company is unprofitable.

What is Hyperfine, Inc.'s free cash flow?

Hyperfine, Inc. (HYPR) had negative free cash flow of $36.8M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in HYPR back in 2019?

Total return calculator · dividends reinvested · 7+ years of data

See returns →